Improved health‐related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours
Katarina Edfeldt(Uppsala University), Camilla Andersson(Uppsala University), Donald Granberg(Uppsala University Hospital), Per Hellman(Uppsala University Hospital), Pernilla Lagergren(Imperial College London), Espen Thiis‐Evensen(Oslo University Hospital), Anders Sundin
Cited by 13
Related Papers
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Oesophageal cancer
|Nature Reviews Disease Primers|2017|1.1k
K <sup>+</sup> Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
|Science|2011|983
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863